Statins, Tregs and cancer

Atherosclerosis. 2008 Jan;196(1):483-484. doi: 10.1016/j.atherosclerosis.2007.09.028. Epub 2007 Oct 30.

Authors

Mark R Goldstein¹, Luca Mascitelli², Francesca Pezzetta³

Affiliations

¹ 9410 Fountain Medical Court, Suite A-200, Bonita Springs, FL 34135, USA. Electronic address: markrgoldstein@comcast.net.
² Comando Brigata Alpina "Julia", Servizio Sanitario, 8 Via S. Agostino, Udine 33100, Italy. Electronic address: lumasci@libero.it.
³ Cardiology Service, Ospedale di San Vito al Tagliamento, San Vito al Tagliamento 33078, Italy. Electronic address: francesca.pezzetta@libero.it.

PMID: 17977547
DOI: 10.1016/j.atherosclerosis.2007.09.028

No abstract available

Publication types

Letter

MeSH terms

Age Factors
Aged
Carcinoma, Hepatocellular / immunology
Clinical Trials as Topic
Forkhead Transcription Factors / drug effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / blood
Immunocompromised Host
Liver Neoplasms / immunology*
T-Lymphocytes, Regulatory / drug effects*
T-Lymphocytes, Regulatory / physiology

Substances

FOXP3 protein, human
Forkhead Transcription Factors
Hydroxymethylglutaryl-CoA Reductase Inhibitors